CLINICAL, IMAGING AND PATHOLOGICAL ASPECTS OF MAMMARY LYMPHOMAS SECONDARY TO MALIGNANT T- CELL CUTANEOUS LYMPHOMAS

Authors

  • Cristian Lungulescu University of Medicine and Pharmacy Craiova, Oncology Department
  • Georgiana-Cristiana Camen
  • Raluca-Elena Nica
  • Viorel Biciusca
  • Teodor-Nicusor Sas

DOI:

https://doi.org/10.52701/monc.2021.v2i1.27

Keywords:

imaging aspects, secondary breast lymphoma, mycosis fungoides

Abstract

Primary cutaneous lymphomas rank as the second most common clinical form of extranodal non-Hogdkin malignant lymphomas. Among non-Hodgkin malignant skin T-cell lymphomas, Mycosis Fungoides (MF) is the most frequent clinical occurence. The MF lymphoma originates in skin-homing helper T-cells, which express the CD4 + marker, showing chronic evolution, with recurrent lesions. In advanced stages, patients with Mycosis Fungoides may experience severe/extensive skin lesions or extracutaneous localizations of the disease. The secondary breast lymphoma is more common in non-Hodgkin malignant lymphoma than in Hodgkin lymphoma. Among the mammographic characteristics of breast lymphoma we mention: oval or round tumor mass, with well-defined or indistinct margins, absence of intratumoral calcifications, presence of intramammary lymph nodes, supra-adjacent skin thickening and lymphedema that causes diffuse increase in breast density. The ultrasound features of breast lymphoma run as follows: it is oval or round in shape, with well-defined or indistinct margins, which in Doppler ultrasound are identified as hypervascularized masses. The description of the imaging features of mammary lymphomas secondary to cutaneous T-cell lymphomas is required before performing the breast core-needle biopsy.

References

Bagherani N, Smoller BR. An overview of cutaneous T cell lymphomas. F1000Research. 2016;5.

https://doi.org/10.12688/f1000research.8829.1

Amorim GM, Niemeyer?Corbellini JP, Quintella DC, Cuzzi T, Ramos?e?Silva M. Hypopigmented mycosis fungoides: a 20?case retrospective series. International journal of dermatology. 2018;57(3):306-12.

https://doi.org/10.1111/ijd.13855

Ghazawi FM, Alghazawi N, Le M, Netchiporouk E, Glassman SJ, Sasseville D, et al. Environmental and other extrinsic risk factors contributing to the pathogenesis of cutaneous T cell lymphoma (CTCL). Frontiers in oncology. 2019;9:300.

https://doi.org/10.3389/fonc.2019.00300

Akinbami AA, Osikomaiya BI, John-Olabode SO, Adediran AA, Osinaike O, Uche EI, et al. Mycosis fungoides: case report and literature review. Clinical Medicine Insights: Case Reports. 2014;7:CCRep. S15724.

https://doi.org/10.4137/CCRep.S15724

Krejsgaard T, Lindahl LM, Mongan NP, Wasik MA, Litvinov IV, Iversen L, et al., editors. Malignant inflammation in cutaneous T?cell lymphoma-a hostile takeover. Seminars in immunopathology; 2017: Springer.

https://doi.org/10.1007/s00281-016-0594-9

Cerroni L. Lymphoproliferative lesions of the skin. Journal of clinical pathology. 2006;59(8):813-26.

https://doi.org/10.1136/jcp.2005.033019

Kadin M, Nasu K, Sako D, Said J, Vonderheid E. Lymphomatoid papulosis. A cutaneous proliferation of activated helper T cells expressing Hodgkin's disease-associated antigens. The American journal of pathology. 1985;119(2):315.

Jennings WC, Baker RS, Murray SS, Howard CA, Parker DE, Peabody LF, et al. Primary breast lymphoma: the role of mastectomy and the importance of lymph node status. Annals of surgery. 2007;245(5):784.

https://doi.org/10.1097/01.sla.0000254418.90192.59

Anne N, Pallapothu R. Lymphoma of the breast: a mimic of inflammatory breast cancer. World journal of surgical oncology. 2011;9(1):1-4.

https://doi.org/10.1186/1477-7819-9-125

Hoimes CJ, Selbst MK, Shafi NQ, Rose MG, Rosado MF. Hodgkin's lymphoma of the breast. Journal of Clinical Oncology. 2010;28(2):e11-e3.

https://doi.org/10.1200/JCO.2009.23.1613

Zack JR, Trevisan SG, Gupta M. Primary breast lymphoma originating in a benign intramammary lymph node. American Journal of Roentgenology. 2001;177(1):177-8.

https://doi.org/10.2214/ajr.177.1.1770177

Yang WT, Lane DL, Le-Petross HT, Abruzzo LV, Macapinlac HA. Breast lymphoma: imaging findings of 32 tumors in 27 patients. Radiology. 2007;245(3):692-702.

https://doi.org/10.1148/radiol.2452061726

Shim E, Song SE, Seo BK, Kim Y-S, Son GS. Lymphoma affecting the breast: a pictorial review of multimodal imaging findings. Journal of breast cancer. 2013;16(3):254.

https://doi.org/10.4048/jbc.2013.16.3.254

Harvey NT, Spagnolo DV, Wood BA. 'Could it be mycosis fungoides?': an approach to diagnosing patch stage mycosis fungoides. Journal of Hematopathology. 2015;8(4):209-23.

https://doi.org/10.1007/s12308-015-0247-2

Smoller BR, Bishop K, Glusac E, Kim YH, Hendrickson M. Reassessment of histologic parameters in the diagnosis of mycosis fungoides. The American journal of surgical pathology. 1995;19(12):1423-30.

https://doi.org/10.1097/00000478-199512000-00009

Zackheim HS, McCalmont TH. Mycosis fungoides: the great imitator. Journal of the American Academy of Dermatology. 2002;47(6):914-8.

https://doi.org/10.1067/mjd.2002.124696

Tebeic? T, Andrei R, Zurac S, St?niceanu F. Practical aspects regarding the histopathological diagnosis of early mycosis fungoides. Romanian Journal Of Internal Medicine. 2016;54(1):3-10.

https://doi.org/10.1515/rjim-2016-0001

Pimpinelli N, Olsen EA, Santucci M, Vonderheid E, Haeffner AC, Stevens S, et al. Defining early mycosis fungoides. Journal of the American Academy of Dermatology. 2005;53(6):1053-63.

https://doi.org/10.1016/j.jaad.2005.08.057

Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression. Archives of dermatology. 2003;139(7):857-66.

https://doi.org/10.1001/archderm.139.7.857

Vonderheid E, Bigler R, Hou J. On the possible relationship between staphylococcal superantigens and increased Vbeta5. 1 usage in cutaneous T-cell lymphoma. The British journal of dermatology. 2005;152(4):825-6; author reply 7.

https://doi.org/10.1111/j.1365-2133.2005.06524.x

Morales M, Olsen J, Johansen P, Kaerlev L, Guénel P, Arveux P, et al. Viral infection, atopy and mycosis fungoides: a European multicentre case-control study. European journal of cancer. 2003;39(4):511-6.

https://doi.org/10.1016/S0959-8049(02)00773-6

Kelati A, Gallouj S, Tahiri L, Harmouche T, Mernissi F. Defining the mimics and clinico-histological diagnosis criteria for mycosis fungoides to minimize misdiagnosis. International journal of women's dermatology. 2017;3(2):100-6.

https://doi.org/10.1016/j.ijwd.2016.11.006

Sanchez JL, Ackerman A. The patch stage of mycosis fungoides. Criteria for histologic diagnosis. The American Journal of Dermatopathology. 1979;1(1):5-26.

https://doi.org/10.1097/00000372-197901010-00002

Santucci M, Biggeri A, Feller AC, Massi D, Burg G. Efficacy of histologic criteria for diagnosing early mycosis fungoides: an EORTC cutaneous lymphoma study group investigation. The American journal of surgical pathology. 2000;24(1):40.

https://doi.org/10.1097/00000478-200001000-00005

Hwang ST, Janik JE, Jaffe ES, Wilson WH. Mycosis fungoides and Sézary syndrome. The Lancet. 2008;371(9616):945-57.

https://doi.org/10.1016/S0140-6736(08)60420-1

Michie S, Abel E, Hoppe R, Warnke R, Wood G. Discordant expression of antigens between intraepidermal and intradermal T cells in mycosis fungoides. The American journal of pathology. 1990;137(6):1447.

Wood GS, Hong SR, Sasaki DT, Abel EA, Hoppe RT, Warnke RA, et al. Leu-8/CD7 antigen expression by CD3+ T cells: comparative analysis of skin and blood in mycosis fungoides/Sezary syndrome relative to normal blood values. Journal of the American Academy of Dermatology. 1990;22(4):602-7.

https://doi.org/10.1016/0190-9622(90)70080-2

Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood, The Journal of the American Society of Hematology. 2011;117(19):5019-32.

https://doi.org/10.1182/blood-2011-01-293050

Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer. 1972;29(6):1705-12.

https://doi.org/10.1002/1097-0142(197206)29:6<1705::AID-CNCR2820290640>3.0.CO;2-I

Moura C, Leite MI, Parreira R, Medeiros A. Primary breast lymphoma. Journal of surgical case reports. 2020;2020(1):rjz405.

https://doi.org/10.1093/jscr/rjz405

Kim YR, Kim HS, Kim H-W. Are irregular hypoechoic breast masses on ultrasound always malignancies?: a pictorial essay. Korean journal of radiology. 2015;16(6):1266.

https://doi.org/10.3348/kjr.2015.16.6.1266

Raj SD, Shurafa M, Shah Z, Raj KM, Fishman MD, Dialani VM. Primary and secondary breast lymphoma: clinical, pathologic, and multimodality imaging review. Radiographics. 2019;39(3):610-25.

https://doi.org/10.1148/rg.2019180097

Melo A, Silva S, Ferreira C, Pereira R, Esteves A, Marques RA, et al. Primary breast lymphoma: A mimic of inflammatory breast cancer. International journal of surgery case reports. 2018;53:410-3.

https://doi.org/10.1016/j.ijscr.2018.11.040

Benner MF, Jansen PM, Vermeer MH, Willemze R. Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases. Blood, The Journal of the American Society of Hematology. 2012;119(7):1643-9.

https://doi.org/10.1182/blood-2011-08-376319

Liberman L, Giess CS, Dershaw DD, Louie DC, Deutch BM. Non-Hodgkin lymphoma of the breast: imaging characteristics and correlation with histopathologic findings. Radiology. 1994;192(1):157-60.

https://doi.org/10.1148/radiology.192.1.8208929

Dimitrov DD, Karamanliev MP, Deliyski TS, Gabarski AV, Vatov PP, Gencheva RO, et al. Diagnostic value of tru-cut biopsy in diagnosing breast lesions. Journal of Biomedical and Clinical Research. 2016;9(2):126-9.

https://doi.org/10.1515/jbcr-2016-0018

Apesteguía L, Pina LJ. Ultrasound-guided core-needle biopsy of breast lesions. Insights into imaging. 2011;2(4):493-500.

https://doi.org/10.1007/s13244-011-0090-7

Downloads

Published

2021-05-25